Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Long-Term Debt Repayments (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Long-Term Debt Repayments for 11 consecutive years, with $312000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments changed 0.0% to $312000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 0.0% change, with the full-year FY2025 number at $1.2 million, changed 0.0% from a year prior.
  • Long-Term Debt Repayments was $312000.0 for Q4 2025 at Ekso Bionics Holdings, roughly flat from $313000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $313000.0 in Q4 2023 to a low of $312000.0 in Q2 2024.
  • A 3-year average of $312555.6 and a median of $313000.0 in 2023 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: fell 0.32% in 2024, then changed 0.0% in 2025.
  • Ekso Bionics Holdings' Long-Term Debt Repayments stood at $313000.0 in 2023, then dropped by 0.32% to $312000.0 in 2024, then changed by 0.0% to $312000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Long-Term Debt Repayments are $312000.0 (Q4 2025), $313000.0 (Q3 2025), and $312000.0 (Q2 2025).